LPHN3 and attention‐deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study

Publisher： John Wiley & Sons Inc

E-ISSN： 1601-183x|14|5|419-427

ISSN： 1601-1848

Source： GENES, BRAIN AND BEHAVIOR (ELECTRONIC), Vol.14, Iss.5, 2015-06, pp. : 419-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sensation‐to‐cognition cortical streams in attention‐deficit/hyperactivity disorder

By  

HUMAN BRAIN MAPPING, Vol. 36, Iss. 7, 2015-07 ,pp. : 2544-2557

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder

By  

CNS: NEUROSCIENCE AND THERAPEUTICS, Vol. 21, Iss. 12, 2015-12 ,pp. : 936-942

John Wiley & Sons Inc

Access to resources Recommend Favorite

Altered salience processing in attention deficit hyperactivity disorder

By  

HUMAN BRAIN MAPPING, Vol. 36, Iss. 6, 2015-06 ,pp. : 2049-2060

John Wiley & Sons Inc

Access to resources Recommend Favorite

Smoking and the developing brain: Altered white matter microstructure in attention‐deficit/hyperactivity disorder and healthy controls

By  

HUMAN BRAIN MAPPING, Vol. 36, Iss. 3, 2015-03 ,pp. : 1180-1189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disrupted functional connectivity of cerebellar default network areas in attention‐deficit/hyperactivity disorder

By  

HUMAN BRAIN MAPPING, Vol. 36, Iss. 9, 2015-09 ,pp. : 3373-3386

John Wiley & Sons Inc

Access to resources Recommend Favorite